Skip to main content
Clinical Trials/ISRCTN99894276
ISRCTN99894276
Active, Not Recruiting
N/A

Exploring the level of efficacy of pelvic floor physiotherapy intervention for the treatment of Genitourinary Syndrome of Menopause (GSM) in women after the treatment of breast cancer

niversity of West Attica0 sites60 target enrollmentJune 15, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Genitourinary Syndrome of Menopause and symptoms of vaginal dryness and sexual dysfunction in women survivors after breast cancer
Sponsor
niversity of West Attica
Enrollment
60
Status
Active, Not Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 15, 2022
End Date
December 31, 2025
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
niversity of West Attica

Eligibility Criteria

Inclusion Criteria

  • Women aged 35\-65 years with :
  • 1\. Pain during and/or after vaginal intercourse, greater than 7/10, based on the Visual Analogue Pain Scale (VAS).
  • 2\. Also, women who have undergone immunosuppressive chemotherapy, received or are receiving adjuvant hormone therapy with tamoxifen (TAM), or aromatase inhibitors (AIs) and report symptoms of vaginal dryness and dyspareunia will also be included.
  • 3\. Willing to be assigned to the study

Exclusion Criteria

  • 1\. Metastatic breast cancer
  • 2\. Vaginal or intravaginal stenosis
  • 3\. Pelvic surgery
  • 4\. Allergy to lubricating oils and moisturizers
  • 5\. Women using hormone replacement therapy (HRT)
  • 6\. Women who are on long\-term use of birth control pills
  • 7\. Women who are on some type of drug intervention for dyspareunia
  • 8\. Diabetes
  • 9\. Hypertension
  • 10\. Obesity

Outcomes

Primary Outcomes

Not specified

Similar Trials